Aubrey Cunnington retweeted
Our Prof Darius Armstrong-James (@DArmstrongJames) is playing a key role in the new Wellcome-funded MycoDTP.
The collaboration aims to develop future leaders in fungal disease research.👇️
citystgeorges.ac.uk/news-and…
Aubrey Cunnington retweeted
⏰ Extended deadline: apply for the #EDCTP Prizes 2027 by 24 September 2026!
🏆 Dr Pascoal Mocumbi Prize | €50K
🏆 Outstanding Research Team Prize | €50K
🏆 Outstanding Female Scientist Prize | €20K
🏆 Scientific Leadership Prizes | €15K each
🔗 edctpforum.eu/edctp-prizes-2…
Aubrey Cunnington retweeted
In a new interview with @SeattleMet, PATH’s Dr. Gonzalo Domingo shares how diagnostics help health workers respond faster and deliver better care, from Ebola response to malaria treatment.
🔗 bit.ly/4hmKFrL
Aubrey Cunnington retweeted
Don't miss this weeks post on #ICYMT_ESPID.
Every week, we revisit a presentation from #ESPID2026 @ESPIDsociety
This week's spotlight💡: @LillyVerhagen
What if the right prevention strategy for respiratory infections depends on where children live?
tinyurl.com/3d9uz8v2
Aubrey Cunnington retweeted
The body's earliest immune response may determine whether people will get flu symptoms. 🤧
Using a human challenge study, researchers were able to build a picture of how immune responses unfold in the initial days after exposure to the virus.👇️
imperial.ac.uk/news/articles…
Congratulations @SinganayagamLab !
Dr Aran Singanayagam (@SinganayagamLab) has been named a 2026 Lister Prize Fellow @ListerInstitute. 🎉
Securing £300k to advance vital research into the lung microbiome, his work explores how respiratory microbes shape health and disease. #ListerPrize2026
imperial.ac.uk/news/articles…
Aubrey Cunnington retweeted
First in the UK, second in the world!
We’ve retained our @WorldUniRanking for the third year in a row! 🎉
This success is thanks to every single member of Imperial’s community, as we work together to make a meaningful difference in the world.
Aubrey Cunnington retweeted
Congratulations to Snitch for winning this year’s WE Innovate – our competition for women-led startups 🎉
The team are developing an app which helps friends cut down their screen time by working together 📱
Find out more and hear from the team as part of @LDNTechWeek 🔽
“We’re building the social solution to screen time.”
Asha Bakhai is the CEO and founder of Snitch and an alum of @ImperialDyson School of Design Engineering.
Snitch is a platform to help to reduce screen time. And for @LDNTechWeek, we asked Asha to explain how she’s brought together a team of design engineers to use behavioural science to tackle the screen time challenge and how Imperial is helping young people with awesome ideas to make them a reality.
Find out more 👇 getsnitch.co.uk/
Aubrey Cunnington retweeted
New research shows that flu infection may increase susceptibility to tuberculosis (TB) by weakening key immune pathways.
The findings suggest seasonal flu vaccines could offer a new tool to help prevent TB in high-risk regions. 💉 👇️
imperial.ac.uk/news/articles…
Aubrey Cunnington retweeted
Calling all graduating students passionate about healthtech! Kickstart your career with an impactful National Service at minoHealth AI Labs.
Join us in revolutionizing healthcare with cutting-edge AI technology. Apply now and be part of the future of health innovation!
Aubrey Cunnington retweeted
Congratulations to Prof Michael Way on being elected a Fellow of the Royal Society 🎉
Professor @imperialcollege and group leader @TheCrick, his work has shaped our understanding of cell signalling and host-pathogen interactions.
👉crick.ac.uk/news/2026-05-27_…
Aubrey Cunnington retweeted
We are currently recruiting Global Health Research (GHR) experts and community engagement and involvement specialists for our GHR committees.
Applications close on 26 May 2026. Find out how to apply: nihr.ac.uk/get-involved/comm…
Aubrey Cunnington retweeted
Research led by Professor @acunningID, honorary consultant in paediatric infectious diseases, lays the groundwork for a new test that could predict how a patient's illness will progress and how they will respond to treatment.
Read more: imperial.ac.uk/news/articles…
@imperialcollege
Aubrey Cunnington retweeted
Antibiotics are losing their power, and the stakes couldn’t be higher. 🧫💊
Featuring our Dr Tim Rawson and Dr Andy Edwards, this @Nature video explores the global threat of antimicrobial resistance, and the race for solutions.
Watch now👇 #AMR
youtube.com/watch?v=B5zByTCK…
Aubrey Cunnington retweeted
The UK has joined a major clinical trial to test an mRNA vaccine for H5N1 influenza.
Commenting in the @Telegraph, Prof John Tregoning (@DrTregoning) says large‑scale trials are vital to rapidly adapt and scale production before the next pandemic.
telegraph.co.uk/global-healt…
Aubrey Cunnington retweeted
Could a simple blood test predict how an illness will unfold?🩸
Scientists in @ImperialInfect have developed VeloCD, a method that can forecast disease progression and treatment response — with potential to transform patient care.🔽
imperial.ac.uk/news/articles…
Aubrey Cunnington retweeted
📢 We're proud to announce the launch of our newest department, Imperial Lifelong Learning.
From Global Summer Experiences to Executive and Professional Education, we empower learners to push the boundaries of education and make an immediate impact ⤵️
imperial.ac.uk/lifelong-lear…
Aubrey Cunnington retweeted
NIHR is launching funding as part of its refreshed global health research programme. The funding will provide opportunities to develop research leadership and capacity, helping prevent and respond to global health security challenges.
Read more here: nihr.ac.uk/news/nihr-launche….

ALT "Investing in global health research leadership turns new ideas into better health. It strengthens research systems to respond to global health security threats and challenges, inform policy, and deliver lasting health impact." Professor Lucy Chappell, Chief Scientific Adviser at Department of Health and Social Care and Chief Executive Officer at NIHR
Rapid, on-farm lab-grade detection of #PRRSV & #SIV is within sight thanks to a @ProtonDx & Emerald Veterinary Health UK field study! We’re testing Dragonfly™ to show how it can provide faster results, leading to better clinical decisions & improved animal welfare. #SwineHealth






















